Log In
Print
BCIQ
Print
Print this Print this
 

Casodex, bicalutamide

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionOral non-steroidal androgen receptor inhibitor
Molecular Target Androgen receptor
Mechanism of ActionAndrogen receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationProstate cancer
Indication DetailsTreat advanced prostate cancer; Treat early-stage prostate cancer; Treat locally advanced non-metastatic prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today